On June 30, 2025, the Federal Circuit issued a precedential decision in Eye Therapies, LLC v. Slayback Pharma, LLC,[1] reversing the Patent Trial and Appeal Board’s (PTAB’s) claim construction of the ...

"As the decision correctly recognizes, the meaning of a statute doesn’t change to fit new contexts; it’s up to Congress to make new law to address new problems," said Judd Littleton, a partner at ...